Hypogonadism: all 352 studies

Page 2 of 4. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.

• A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone GelCompletedNCT01665599Phase 3Results posted
• Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary HypogonadismCompletedNCT01534208Phase 3Results posted
• Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary HypogonadismCompletedNCT01532414Phase 3Results posted
• Testosterone and Alendronate in Hypogonadal MenTerminatedNCT01460654Phase 2Results posted
• Safety and Efficacy of Intranasal TBS-1 Treatment of Male HypogonadismCompletedNCT01446042Phase 3Results posted
• A Study of Ejaculatory Dysfunction in Men With Low Testosterone LevelsCompletedNCT01419236Phase 2Results posted
• Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal MenCompletedNCT01403116Phase 3Results posted
• The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)CompletedNCT01386606Phase 2Results posted
• CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone TherapyCompletedNCT01378299Phase 1Results posted
• Efficacy, Pharmacokinetics and Safety of TestosteroneCompletedNCT01370369Phase 2Results posted
• Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal SystemsCompletedNCT01323140Phase 2Results posted
• Normalization of Morning Testosterone Levels in Men With Secondary HypogonadismCompletedNCT01270841Phase 2Results posted
• Efficacy of an Intranasal Testosterone ProductCompletedNCT01252745Phase 2Results posted
• Time to Eugonadal Range, Time to Steady State and Drying TimeCompletedNCT01228071Phase 3Results posted
• Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal MenTerminatedNCT01200862Phase 2Results posted
• Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes MellitusCompletedNCT01191320Phase 2Results posted
• Hypogonadism in Young Men With Type 2 DiabetesTerminatedNCT01155518Phase 2Results posted
• ESPRIT Study in Hypogonadal MenCompletedNCT01143818Results posted
• Testosterone Replacement in Men With Diabetes and ObesityCompletedNCT01127659Phase 4Results posted
• Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal MenCompletedNCT01104246Phase 1Results posted
• A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic HypogonadismCompletedNCT01084265Phase 3Results posted
• Efficacy and Tolerability of an Intra-Nasal Testosterone ProductCompletedNCT00975650Phase 2Results posted
• Cycled Testosterone Replacement StudyCompletedNCT00957528Phase 1Results posted
• Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate FormulationCompletedNCT00924612Phase 2Results posted
• Pharmacokinetic Study to Determine Time to Steady-stateCompletedNCT00911586Phase 2Results posted
• A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion FormulationsCompletedNCT00857961Phase 2Results posted
• A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion FormulationsCompletedNCT00857454Phase 3Results posted
• Testosterone for Penile Rehabilitation After Radical ProstatectomyTerminatedNCT00848497Early Phase 1Results posted
• Estrogen Dosing in Turner Syndrome: Pharmacology and MetabolismCompletedNCT00837616Phase 4Results posted
• To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical TestosteroneCompletedNCT00706719Phase 2Results posted
• A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) FormulationsCompletedNCT00702650Phase 3Results posted
• Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal MenCompletedNCT00695110Phase 2Results posted
• ORAL T-6: Oral Androgens in Man-6CompletedNCT00663793Phase 1Results posted
• A Study of Fortigel Testosterone Gel 2% in Males With Low TestosteroneCompletedNCT00522431Phase 3Results posted
• Testosterone for Peripheral Vascular DiseaseCompletedNCT00504712Phase 4Results posted
• 5-Alpha Reductase and Anabolic Effects of TestosteroneCompletedNCT00475501Phase 2Results posted
• Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic HypogonadismTerminatedNCT00467987Not applicableResults posted
• Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal MenCompletedNCT00467870Phase 3Results posted
• Testosterone Treatment for Hypogonadal MenCompletedNCT00433199Phase 3Results posted
• Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese MenCompletedNCT00365794Phase 2Results posted
• Effects of Testosterone Replacement on Pain Sensitivity and Pain PerceptionCompletedNCT00351819Phase 2Results posted
• Effect of Androgel on Type 2 Diabetic Males With HypogonadismCompletedNCT00350701Phase 4Results posted
• Exercise and Testosterone Therapy in Elderly Men With Physical FrailtyCompletedNCT00345969Phase 3Results posted
• Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])TerminatedNCT00328926Phase 4Results posted
• Testosterone Replacement in Older Men and Atherosclerosis ProgressionCompletedNCT00287586Phase 4Results posted
• Testosterone Replacement Therapy in Chronic Spinal Cord InjuryCompletedNCT00266864Phase 2/3Results posted
• TOM: Testosterone in Older Men With SarcopeniaTerminatedNCT00240981Phase 4Results posted
• TRADE-Testosterone Replacement and Dutasteride EffectivenessCompletedNCT00194675Phase 4Results posted
• Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or PlaceboCompletedNCT00179517Phase 2Results posted
• Anastrozole Administration in Elderly Hypogonadal MenCompletedNCT00136695Phase 2Results posted
• Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.CompletedNCT00104572Phase 2Results posted
• Testosterone and Growth Hormone for Bone Loss in MenCompletedNCT00080483Phase 2Results posted
• Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With HypogonadismTerminatedNCT00064987Phase 2Results posted
• A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male ParticipantsCompletedNCT07097259Phase 1
• The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and ObesityCompletedNCT06489457Phase 3
• A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 MonthsCompletedNCT06385509Phase 4
• 7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement TherapySuspendedNCT06191575
• The Molecular Basis of Inherited Reproductive DisordersCompletedNCT05971836
• Low Energy Availability and Pituitary Function (LEAP Study)Status unknownNCT05808647Not applicable
• Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic MenCompletedNCT05806723Phase 4
• Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in MenStatus unknownNCT05773183
• Hypothalamic-pituitary Dysfunction in DiabetesCompletedNCT05752591
• Kisspeptin Administration Subcutaneously to Patients With Reproductive DisordersCompletedNCT05633966Phase 1
• Evaluation of FPT-20 for the Treatment of Spermatogenesis and Semen DisordersCompletedNCT05399212Not applicable
• Natesto Spermatogenesis RebootCompletedNCT05381831Phase 4
• Perioperative Testosterone Replacement Therapy in Sarcopenic Male Colorectal Cancer PatientsStatus unknownNCT05367284
• Impact of Exogenous Estrogens on Cotisol Levels During Synacthen StimulationStatus unknownNCT05302726Not applicable
• A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS TrialTerminatedNCT05205837Phase 4
• Efficacy of Prolonged GnRH Test in Male Adolescents With Postoperative HHStatus unknownNCT05184374Not applicable
• Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin TherapyCompletedNCT05110391
• A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone GelStatus unknownNCT04976595Phase 4
• The Impact of Sinopharm COVID-19 Vaccination on Male FertilityStatus unknownNCT04946565
• Patient and Healthcare Professional Views on Genetic/Genomic Information and TestingActive, not recruitingNCT04733274
• Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low TestosteroneActive, not recruitingNCT04731376Phase 1
• The Effects of Natesto For Treatment Of HypogonadismWithdrawnNCT04717362Early Phase 1
• D-chiroinositol Administration in Hypogonadal MalesCompletedNCT04708249Not applicable
• A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845CompletedNCT04673682Phase 1
• Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality-ObsCompletedNCT04630275
• Vogelxo(R) ABPM Study in Hypogandal MenCompletedNCT04558567Phase 4
• Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in TransmenCompletedNCT04545450Phase 3
• Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; VitalityCompletedNCT04492553Phase 2
• Salivary Testosterone in Men: Diurnal Variation and Post-Prandial ResponsesCompletedNCT04326673
• Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen DeficiencyActive, not recruitingNCT04301765Phase 2
• Assessment of Blood From Men Receiving Oral TU in Various Collection TubesCompletedNCT03973840Phase 1
• Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2)CompletedNCT03792321Phase 4
• Gonadal Function in Young to Middle Aged HIV-infected MenCompletedNCT03747003
• Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.CompletedNCT03619330Phase 4
• Testosterone-Dependent Effects on Protein Biomarkers From Healthy MalesCompletedNCT03541395Not applicable
• Association Between the Prevalence of Cardiovascular Risk Factors and New Use of TestosteroneCompletedNCT03484260
• Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes MellitusCompletedNCT03437109
• Extragonadal Effects of hCG on Calcium HomeostasisCompletedNCT03418896Phase 1
• Evaluation of Testosterone Nasal Gel in Hypogonadal BoysTerminatedNCT03345797Phase 1
• Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.Status unknownNCT03281187Phase 3
• Long-term Lifestyle Change and Testosterone ReplacementCompletedNCT03256292
• Calciotropic Effects After HCG Stimulation TestCompletedNCT03254641
• Periodontal Profile of Hypogonadic MenWithdrawnNCT03176537Phase 4
• Effects of Testosterone on Myocardial RepolarizationCompletedNCT03126656Phase 4
• Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)TerminatedNCT03118479Phase 1
• Effect of 12 Weeks of Acupuncture on AMH and COH in Low Responder PatientsStatus unknownNCT03080584Not applicable
• Efficacy of Fenugreek Seed and Lespedeza Cuneata in TDSCompletedNCT03057899Phase 4

← Hypogonadism overview